NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
28.72
-1.73 (-5.68%)
Apr 28, 2026, 4:00 PM EDT - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $3.30 billion as of April 29, 2026. Its market cap has increased by 101.80% in one year.
Market Cap
3.30B
Enterprise Value
2.57B
1-Year Change
101.80%
Ranking
Category
Stock Price
$28.72
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.30B, an increase of 2,037.98%. That is a compound annual growth rate of 79.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 3.50B | -11.99% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 3.74B |
| Travere Therapeutics | 3.74B |
| Tango Therapeutics | 3.72B |
| Telix Pharmaceuticals | 3.61B |
| Oruka Therapeutics | 3.47B |
| Edgewise Therapeutics | 3.39B |
| Catalyst Pharmaceuticals | 3.34B |
| Structure Therapeutics | 3.22B |